share_log

Watching MIRA Pharmaceuticals; Zacks Small-Cap Research Gives Stock $17.75 Price Valuation, Says Co Is Creating A THC Analog That Has The Same Benefits As THC Without The Negative Side Effects

Benzinga ·  Oct 21 22:09
Watching MIRA Pharmaceuticals; Zacks Small-Cap Research Gives Stock $17.75 Price Valuation, Says Co Is Creating A THC Analog That Has The Same Benefits As THC Without The Negative Side Effects
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment